June 11, 2021
Women are conspicuously absent as leaders of cardiovascular clinical trials—now, an “actionable road map” aims to rectify this imbalance by itemizing the core competencies required to lead a clinical trial, and by offering concrete steps that institutions, professional societies, industry, and public funding agencies can take to ensure clinical trials get more female principal investigators and chairs.
“We must adopt transformative strategies to harness the strengths of women as CV clinical trial leaders and deconstruct the sexism that has been normalized in the clinical trial enterprise,” the authors write. “For far too long, recruitment, advancement, mentorship, and sponsorship have followed gender lines, with decisions generally made by men for men.”